2289 — Charmacy Pharmaceutical Co Cashflow Statement
0.000.00%
Consumer DefensivesAdventurousSmall CapTurnaround
- HK$864.00m
- HK$908.82m
- CNY4.18bn
- 41
- 83
- 88
- 85
Annual cashflow statement for Charmacy Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | CAS | CAS | CAS | CAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Changes in Working Capital | 49.2 | 4.02 | 131 | -19.5 | — |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 49.2 | 4.02 | 131 | -19.5 | — |
Capital Expenditures | -97.7 | -73.9 | -52 | -25 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.157 | 0.16 | -2.8 | 0.638 | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -97.6 | -73.7 | -54.8 | -24.4 | — |
Financing Cash Flow Items | 8.36 | -156 | -68.1 | -63.1 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 29.2 | 54.1 | -2.68 | 74.4 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -19.4 | -15.6 | 73.6 | 30.5 | — |